{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T19:30:51Z","timestamp":1765827051539},"reference-count":11,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2012,11,15]],"date-time":"2012-11-15T00:00:00Z","timestamp":1352937600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2013,6]]},"DOI":"10.1007\/s00277-012-1622-z","type":"journal-article","created":{"date-parts":[[2012,11,14]],"date-time":"2012-11-14T12:35:30Z","timestamp":1352896530000},"page":"845-846","source":"Crossref","is-referenced-by-count":31,"title":["Relapse of aHUS after discontinuation of therapy with eculizumab in a patient with aHUS and factor H mutation"],"prefix":"10.1007","volume":"92","author":[{"given":"Ryan","family":"Carr","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Spero R.","family":"Cataland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,11,15]]},"reference":[{"issue":"17","key":"1622_CR1","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1056\/NEJMra0902814","volume":"361","author":"M Noris","year":"2009","unstructured":"Noris M, Remuzzi G (2009) Atypical hemolytic\u2013uremic syndrome. N Engl J Med 361(17):1676\u20131687. doi: 10.1056\/NEJMra0902814","journal-title":"N Engl J Med"},{"issue":"12","key":"1622_CR2","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1056\/NEJMoa061648","volume":"355","author":"P Hillmen","year":"2006","unstructured":"Hillmen P, Young NS, Schubert J, Brodsky RA, Socie G, Muus P, Roth A, Szer J, Elebute MO, Nakamura R, Browne P, Risitano AM, Hill A, Schrezenmeier H, Fu CL, Maciejewski J, Rollins SA, Mojcik CF, Rother RP, Luzzatto L (2006) The complement inhibitor eculizumab in paroxysmal nocturnal hemoglobinuria. N Engl J Med 355(12):1233\u20131243. doi: 10.1056\/NEJMoa061648","journal-title":"N Engl J Med"},{"issue":"25","key":"1622_CR3","doi-asserted-by":"crossref","first-page":"6786","DOI":"10.1182\/blood-2011-02-333997","volume":"117","author":"RJ Kelly","year":"2011","unstructured":"Kelly RJ, Hill A, Arnold LM, Brooksbank GL, Richards SJ, Cullen M, Mitchell LD, Cohen DR, Gregory WM, Hillmen P (2011) Long-term treatment with eculizumab in paroxysmal nocturnal hemoglobinuria: sustained efficacy and improved survival. Blood 117(25):6786\u20136792. doi: 10.1182\/blood-2011-02-333997","journal-title":"Blood"},{"issue":"4","key":"1622_CR4","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1007\/s00467-010-1708-6","volume":"26","author":"SI Al-Akash","year":"2011","unstructured":"Al-Akash SI, Almond PS, Savell VH Jr, Gharaybeh SI, Hogue C (2011) Eculizumab induces long-term remission in recurrent post-transplant HUS associated with C3 gene mutation. Pediatr Nephrol 26(4):613\u2013619. doi: 10.1007\/s00467-010-1708-6","journal-title":"Pediatr Nephrol"},{"issue":"10","key":"1622_CR5","doi-asserted-by":"crossref","first-page":"4353","DOI":"10.1016\/j.transproceed.2010.09.125","volume":"42","author":"V Chatelet","year":"2010","unstructured":"Chatelet V, Lobbedez T, Fremeaux-Bacchi V, Ficheux M, Ryckelynck JP, Hurault de Ligny B (2010) Eculizumab: safety and efficacy after 17\u00a0months of treatment in a renal transplant patient with recurrent atypical hemolytic-uremic syndrome: case report. Transplant Proc 42(10):4353\u20134355. doi: 10.1016\/j.transproceed.2010.09.125","journal-title":"Transplant Proc"},{"issue":"5","key":"1622_CR6","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1056\/NEJMc0809959","volume":"360","author":"RA Gruppo","year":"2009","unstructured":"Gruppo RA, Rother RP (2009) Eculizumab for congenital atypical hemolytic\u2013uremic syndrome. N Engl J Med 360(5):544\u2013546. doi: 10.1056\/NEJMc0809959","journal-title":"N Engl J Med"},{"issue":"4","key":"1622_CR7","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1007\/s00467-010-1719-3","volume":"26","author":"AL Lapeyraque","year":"2011","unstructured":"Lapeyraque AL, Fremeaux-Bacchi V, Robitaille P (2011) Efficacy of eculizumab in a patient with factor-H-associated atypical hemolytic uremic syndrome. Pediatr Nephrol 26(4):621\u2013624. doi: 10.1007\/s00467-010-1719-3","journal-title":"Pediatr Nephrol"},{"issue":"8","key":"1622_CR8","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.2215\/CJN.01090209","volume":"4","author":"CJ Mache","year":"2009","unstructured":"Mache CJ, Acham-Roschitz B, Fremeaux-Bacchi V, Kirschfink M, Zipfel PF, Roedl S, Vester U, Ring E (2009) Complement inhibitor eculizumab in atypical hemolytic uremic syndrome. Clin J Am Soc Nephrol 4(8):1312\u20131316. doi: 10.2215\/CJN.01090209","journal-title":"Clin J Am Soc Nephrol"},{"issue":"5","key":"1622_CR9","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1056\/NEJMc0808527","volume":"360","author":"J Nurnberger","year":"2009","unstructured":"Nurnberger J, Philipp T, Witzke O, Opazo Saez A, Vester U, Baba HA, Kribben A, Zimmerhackl LB, Janecke AR, Nagel M, Kirschfink M (2009) Eculizumab for atypical hemolytic-uremic syndrome. N Engl J Med 360(5):542\u2013544. doi: 10.1056\/NEJMc0808527","journal-title":"N Engl J Med"},{"issue":"12","key":"1622_CR10","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1002\/ajh.21862","volume":"85","author":"HC Prescott","year":"2010","unstructured":"Prescott HC, Wu HM, Cataland SR, Baiocchi RA (2010) Eculizumab therapy in an adult with plasma exchange-refractory atypical hemolytic uremic syndrome. Am J Hematol 85(12):976\u2013977. doi: 10.1002\/ajh.21862","journal-title":"Am J Hematol"},{"issue":"1","key":"1622_CR11","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/nrneph.2010.155","volume":"7","author":"J Zuber","year":"2011","unstructured":"Zuber J, Le Quintrec M, Sberro-Soussan R, Loirat C, Fremeaux-Bacchi V, Legendre C (2011) New insights into postrenal transplant hemolytic uremic syndrome. Nat Rev Nephrol 7(1):23\u201335. doi: 10.1038\/nrneph.2010.155","journal-title":"Nat Rev Nephrol"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-012-1622-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00277-012-1622-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-012-1622-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T09:50:28Z","timestamp":1559037028000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00277-012-1622-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,11,15]]},"references-count":11,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2013,6]]}},"alternative-id":["1622"],"URL":"https:\/\/doi.org\/10.1007\/s00277-012-1622-z","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,11,15]]}}}